Marina V. Zhdanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marina V. Zhdanova has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Gennadiy Ayzikovich Novik
Saint Petersburg State Pediatric Medical University
9 shared publications - Olga B. Tamrazova
Russian University of Medicine (ROSUNIMED); Russian Medical Academy of Continuous Professional Education; Bashlyaeva City Children’s Clinical Hospital
5 shared publications - Anait V. Tamrazova
Central State Medical Academy of Department for Presidential Affairs of the Russian Federation
4 shared publications - A. G. Sukhotina
Russian University of Medicine (ROSUNIMED); Bashlyaeva City Children’s Clinical Hospital
2 shared publications - Gayane E. Bagramova
Federal Clinical Research Centre for Specialized Healthcare and Medical Technology of Russia’s Federal Medical-Biological Agency
2 shared publications - Андрей Вячеславович Сантимов
Saint Petersburg State Pediatric Medical University
2 shared publications
Latest Publications
- Open Access
- 11 September 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 11,p. 178-186
Hypersensitivity reactions to arthropod bites and stings: Current concepts in pathogenesis, diagnosis, and treatment
Arthropod bites and stings are one of the most common reasons for patients to consult dermatologists, allergists, and pediatricians. Despite the widespread occurrence of this pathology, the clinical manifestations of reactions to arthropod bites remain diverse and can range from physiological local inflammatory changes to severe allergic, toxic and infectious complications. The review selected literary sources from the electronic databases PubMed/MEDLINE, eLIBRARY.RU, Cochrane Library, Google Scholar for the period from 1994 to 2025. As a result of excluding duplicates and applying the selection criteria, 33 literature sources were analyzed. In the Russian Federation, the most frequent contact of the population occurs with bloodsucking diptera insects, which has the collective name “wildebeest”, which includes mosquitoes, midges, woodlice and horseflies. The review presents current data on the classification of damage caused by blood-sucking and stinging arthropods, examines the main mechanisms of local and systemic reactions, as well as the features of the immune response to saliva and venom antigens. The main attention is paid to skin manifestations, which are most common in dermatological practice. Uncomplicated local reactions, large local reactions, Skeeter syndrome, papular urticaria, granulomatous and pseudolymphomatous reactions, secondary bacterial complications, as well as systemic allergic reactions, including angioedema and anaphylaxis, are considered in detail. The clinical significance of bullous reactions as a possible marker of lymphoproliferative diseases in adult patients is discussed separately. Modern approaches to the treatment of arthropod bites and stings are presented. It has been shown that the majority of local allergic complications are based not only on histamine-mediated mechanisms, but also on cell-mediated inflammation, which justifies the use of topical glucocorticosteroids as first-line therapy. Special attention is paid to methylprednisolone aceponate as a modern non-halogenated topical glucocorticosteroid with a high safety profile, approved for use in children from the age of four months.
- 11 September 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 11,p. 178-186
Open AccessHypersensitivity reactions to arthropod bites and stings: Current concepts in pathogenesis, diagnosis, and treatment
Arthropod bites and stings are one of the most common reasons for patients to consult dermatologists, allergists, and pediatricians. Despite the widespread occurrence of this pathology, the clinical manifestations of reactions to arthropod bites remain diverse and can range from physiological local inflammatory changes to severe allergic, toxic and infectious complications. The review selected literary sources from the electronic databases PubMed/MEDLINE, eLIBRARY.RU, Cochrane Library, Google Scholar for the period from 1994 to 2025. As a result of excluding duplicates and applying the selection criteria, 33 literature sources were analyzed. In the Russian Federation, the most frequent contact of the population occurs with bloodsucking diptera insects, which has the collective name “wildebeest”, which includes mosquitoes, midges, woodlice and horseflies. The review presents current data on the classification of damage caused by blood-sucking and stinging arthropods, examines the main mechanisms of local and systemic reactions, as well as the features of the immune response to saliva and venom antigens. The main attention is paid to skin manifestations, which are most common in dermatological practice. Uncomplicated local reactions, large local reactions, Skeeter syndrome, papular urticaria, granulomatous and pseudolymphomatous reactions, secondary bacterial complications, as well as systemic allergic reactions, including angioedema and anaphylaxis, are considered in detail. The clinical significance of bullous reactions as a possible marker of lymphoproliferative diseases in adult patients is discussed separately. Modern approaches to the treatment of arthropod bites and stings are presented. It has been shown that the majority of local allergic complications are based not only on histamine-mediated mechanisms, but also on cell-mediated inflammation, which justifies the use of topical glucocorticosteroids as first-line therapy. Special attention is paid to methylprednisolone aceponate as a modern non-halogenated topical glucocorticosteroid with a high safety profile, approved for use in children from the age of four months.
- Open Access
- 23 July 2026
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 25 (2) , 73-83
Efficacy and safety of amino acid-based formulas in the management of infants with cow’s milk protein allergy: an open-label prospective controlled study
Aim. To determine the efficacy and safety of long-term use of an amino acid-based formula in children with cow›s milk protein allergy (CMPA) and moderate to severe atopic dermatitis (AD). Materials and methods. The study included 60 children under 12 months of age with CMPA presenting with cutaneous symptoms (moderate or severe AD according to the oSCORAD) and/or gastrointestinal symptoms. Prior to the study, all patients were prescribed an extensively hydrolyzed formula (EHF) for 4 weeks. Patients with no or incomplete response to EHF ( n = 30) were assigned to Group 1, receiving an amino acid-based formula (AAF) for 12 months. The 30 patients who showed a positive response to EHF were assigned to Group 2. Results. Children in Group 1 showed greater gains in weight and height during the first 6 months compared to children in Group 2 ( p < 0.001). The resolution of gastrointestinal symptoms in children receiving AAF was observed within 14 days along with an improvement in the clinical picture of AD within 3–5 days. Also, both groups showed a decrease in oSCORAD and EASI scores; however, children receiving AAF had a significantly smaller number of exacerbations ( p = 0.041) and a lower impact of dermatosis on daily activities ( p = 0.002). After 6 months of therapy, 53.3% of children in Group 1 developed tolerance to cow’s milk proteins, compared to only 23.3% in Group 2 ( p = 0.017). After 2 years of follow-up, tolerance was noted in all children who received AAF versus 87.7% of those fed with EHF. Conclusion. The use of AAF in children with CMPA is an effective dietary management method that leads to faster resolution of gastrointestinal symptoms, improvement in the course of atopic dermatitis, and prolongation of its remission. It shortens the period for tolerance development, has a positive effect on the child›s physical development, and contributes to a significant improvement in the quality of life of both patients and their parents.
- 23 July 2026
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 25 (2) , 73-83
Open AccessEfficacy and safety of amino acid-based formulas in the management of infants with cow’s milk protein allergy: an open-label prospective controlled study
Aim. To determine the efficacy and safety of long-term use of an amino acid-based formula in children with cow›s milk protein allergy (CMPA) and moderate to severe atopic dermatitis (AD). Materials and methods. The study included 60 children under 12 months of age with CMPA presenting with cutaneous symptoms (moderate or severe AD according to the oSCORAD) and/or gastrointestinal symptoms. Prior to the study, all patients were prescribed an extensively hydrolyzed formula (EHF) for 4 weeks. Patients with no or incomplete response to EHF ( n = 30) were assigned to Group 1, receiving an amino acid-based formula (AAF) for 12 months. The 30 patients who showed a positive response to EHF were assigned to Group 2. Results. Children in Group 1 showed greater gains in weight and height during the first 6 months compared to children in Group 2 ( p < 0.001). The resolution of gastrointestinal symptoms in children receiving AAF was observed within 14 days along with an improvement in the clinical picture of AD within 3–5 days. Also, both groups showed a decrease in oSCORAD and EASI scores; however, children receiving AAF had a significantly smaller number of exacerbations ( p = 0.041) and a lower impact of dermatosis on daily activities ( p = 0.002). After 6 months of therapy, 53.3% of children in Group 1 developed tolerance to cow’s milk proteins, compared to only 23.3% in Group 2 ( p = 0.017). After 2 years of follow-up, tolerance was noted in all children who received AAF versus 87.7% of those fed with EHF. Conclusion. The use of AAF in children with CMPA is an effective dietary management method that leads to faster resolution of gastrointestinal symptoms, improvement in the course of atopic dermatitis, and prolongation of its remission. It shortens the period for tolerance development, has a positive effect on the child›s physical development, and contributes to a significant improvement in the quality of life of both patients and their parents.
- Open Access
- 1 November 2025
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 63 (5) , 510-516
Eating disorders in children with rheumatic diseases
The high comorbidity of eating disorders, especially anorexia nervosa, and various autoimmune diseases is well known but only a few foreign publications address the prevalence and course of eating disorders in children with immuneinflammatory rheumatic diseases, while in the domestic scientific press the problem of comorbidity of eating disorders and rheumatic diseases isn’t still discussed, neither in children nor in adult patients The aim of this review is to try to fill this gap in the Russian-language scientific literature by summarizing the data available in foreign publications on eating disorders in patients suffering from juvenile-onset systemic lupus erythematosus, juvenile idiopathic arthritis, juvenile fibromyalgia and other syndromes of chronic musculoskeletal pain, as well as hyperuricemia.
- 1 November 2025
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 63 (5) , 510-516
Open AccessEating disorders in children with rheumatic diseases
The high comorbidity of eating disorders, especially anorexia nervosa, and various autoimmune diseases is well known but only a few foreign publications address the prevalence and course of eating disorders in children with immuneinflammatory rheumatic diseases, while in the domestic scientific press the problem of comorbidity of eating disorders and rheumatic diseases isn’t still discussed, neither in children nor in adult patients The aim of this review is to try to fill this gap in the Russian-language scientific literature by summarizing the data available in foreign publications on eating disorders in patients suffering from juvenile-onset systemic lupus erythematosus, juvenile idiopathic arthritis, juvenile fibromyalgia and other syndromes of chronic musculoskeletal pain, as well as hyperuricemia.
- Open Access
- 25 October 2025
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Children's medicine of the North-West
- Vol. 13 (3) , 56-72
Методы альтернативной и комплементарной медицины в педиатрической ревматологии
Многие пациенты, страдающие различными хроническими заболеваниями, обращаются к методам комплементарной и альтернативной медицины, применение которых далеко не всегда основывается на принципах доказательной медицины, хотя многие из них часто используются в реальной клинической практике. В отечественной научной печати методам комплементарной и альтернативной медицины в педиатрической ревматологии посвящены единичные публикации, главным образом, представляющие собой обзорные статьи, обобщающие опыт применения различных диет и пищевых добавок в лечении ревматических заболеваний у детей. При этом многие родители маленьких пациентов, страдающих ревматическими заболеваниями, самостоятельно обращаются за дополнительной помощью к методам комплементарной и альтернативной медицины или задают врачам-ревматологам вопросы о возможности использования тех или иных методов комплементарной и альтернативной медицины в комплексном лечении их ребенка. У практических врачей далеко не всегда имеются ответы на эти вопросы, соответствующие современному состоянию научных знаний о данной проблеме. Цель настоящего обзора — обобщить имеющиеся зарубежные публикации, посвященные применению методов комплементарной и альтернативной медицины в лечении ревматических заболеваний у детей. Many patients suffering from various chronic diseases turn to complementary and alternative medicine methods, the use of which is not always based on the principles of evidence-based medicine, although many of them are often used in real clinical practice. In the Russian scientific press, there are isolated publications devoted to the methods of complementary and alternative medicine in pediatric rheumatology, mainly review articles summarizing the experience of using various diets and dietary supplements in the treatment of rheumatic diseases in children. At the same time, many parents of young patients suffering from rheumatic diseases independently seek additional help from complementary and alternative medicine methods, or ask rheumatologists questions about the possibility of using certain complementary and alternative medicine methods in the comprehensive treatment of their child. Whereas practitioners do not always have answers to these questions that meet the current state of scientific knowledge about this problem. The purpose of this review is to summarize the available foreign publications on the use of complementary and alternative medicine methods in the treatment of rheumatic diseases in children.
- 25 October 2025
- Published by Saint Petersburg State Pediatric Medical University of the Ministry of Health of Russia in Children's medicine of the North-West
- Vol. 13 (3) , 56-72
Open AccessМетоды альтернативной и комплементарной медицины в педиатрической ревматологии
Многие пациенты, страдающие различными хроническими заболеваниями, обращаются к методам комплементарной и альтернативной медицины, применение которых далеко не всегда основывается на принципах доказательной медицины, хотя многие из них часто используются в реальной клинической практике. В отечественной научной печати методам комплементарной и альтернативной медицины в педиатрической ревматологии посвящены единичные публикации, главным образом, представляющие собой обзорные статьи, обобщающие опыт применения различных диет и пищевых добавок в лечении ревматических заболеваний у детей. При этом многие родители маленьких пациентов, страдающих ревматическими заболеваниями, самостоятельно обращаются за дополнительной помощью к методам комплементарной и альтернативной медицины или задают врачам-ревматологам вопросы о возможности использования тех или иных методов комплементарной и альтернативной медицины в комплексном лечении их ребенка. У практических врачей далеко не всегда имеются ответы на эти вопросы, соответствующие современному состоянию научных знаний о данной проблеме. Цель настоящего обзора — обобщить имеющиеся зарубежные публикации, посвященные применению методов комплементарной и альтернативной медицины в лечении ревматических заболеваний у детей. Many patients suffering from various chronic diseases turn to complementary and alternative medicine methods, the use of which is not always based on the principles of evidence-based medicine, although many of them are often used in real clinical practice. In the Russian scientific press, there are isolated publications devoted to the methods of complementary and alternative medicine in pediatric rheumatology, mainly review articles summarizing the experience of using various diets and dietary supplements in the treatment of rheumatic diseases in children. At the same time, many parents of young patients suffering from rheumatic diseases independently seek additional help from complementary and alternative medicine methods, or ask rheumatologists questions about the possibility of using certain complementary and alternative medicine methods in the comprehensive treatment of their child. Whereas practitioners do not always have answers to these questions that meet the current state of scientific knowledge about this problem. The purpose of this review is to summarize the available foreign publications on the use of complementary and alternative medicine methods in the treatment of rheumatic diseases in children.
- 1 July 2025
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 24 (3)
Diagnosis and treatment of local forms of alopecia areata in children
Alopecia areata (AA) is a genetically caused chronic autoimmune disease, which is characterized by nonscarring temporary or persistent hair loss. The prevalence of this disease has increased in recent decades, and currently up to 3.83% of patients in dermatological facilities seek care with the problem of focal hair loss. The incidence of AA in children increases with age. Thus, the highest prevalence is recorded among adolescents aged 12—17 years. It has also been observed that concomitant autoimmune diseases are 2.59 times more often found in children with AA than in children without AA. Focal hair loss affects everyday life, always significantly reducing the quality of life. AA multifactorial pathogenesis, recurrent course as well as visible cosmetic defect necessitate a comprehensive approach in the diagnosis and treatment of this condition, as well as the most effective modern treatment methods application. The article discusses epidemiology, etiology, development mechanisms, clinical features of AA, describes the main methods of diagnosis and control of performed therapy, particularly trichoscopic signs, presents the most commonly used scales for determining the process severity as well as modern methods of managing patients with localized form of the disease, practical application of which is demonstrated in a clinical case.
- 1 July 2025
- Published by Media Sphere Publishing Group in Russian Journal of Clinical Dermatology and Venereology
- Vol. 24 (3)
Diagnosis and treatment of local forms of alopecia areata in children
Alopecia areata (AA) is a genetically caused chronic autoimmune disease, which is characterized by nonscarring temporary or persistent hair loss. The prevalence of this disease has increased in recent decades, and currently up to 3.83% of patients in dermatological facilities seek care with the problem of focal hair loss. The incidence of AA in children increases with age. Thus, the highest prevalence is recorded among adolescents aged 12—17 years. It has also been observed that concomitant autoimmune diseases are 2.59 times more often found in children with AA than in children without AA. Focal hair loss affects everyday life, always significantly reducing the quality of life. AA multifactorial pathogenesis, recurrent course as well as visible cosmetic defect necessitate a comprehensive approach in the diagnosis and treatment of this condition, as well as the most effective modern treatment methods application. The article discusses epidemiology, etiology, development mechanisms, clinical features of AA, describes the main methods of diagnosis and control of performed therapy, particularly trichoscopic signs, presents the most commonly used scales for determining the process severity as well as modern methods of managing patients with localized form of the disease, practical application of which is demonstrated in a clinical case.
- Open Access
- 30 March 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 2,p. 42-48
Recognizing secondary infection in patients with atopic dermatitis: Head & neck atopic dermatitis
Atopic dermatitis is a hereditary chronic skin disease characterized by severe itching, recurrent course and association with other diseases of atopic nature, as well as numerous complications, which include the addition of a secondary infection. Head and neck atopic dermatitis (HNAD) is a special phenotype of atopic dermatitis that occurs in adolescents and adults. A characteristic feature of HNAD is the lesion of skin areas rich in sebaceous glands (face, neck, upper third of the chest and back), which is associated with the active participation of Malassezia fungi in the pathogenesis of the dermatosis. The multifactorial pathogenesis of HNAD, often persistent course, the impossibility of complete elimination of the provoking factor, as well as the addition of a secondary bacterial infection against the background of itching, necessitate a comprehensive approach to the treatment of this condition and the use of combination drugs containing a glucocorticosteroid, an antimycotic and an antibiotic to relieve exacerbations. The article examines the etiology, mechanisms of development of HNAD, clinical features, as well as modern methods of therapy, the practical application of which is demonstrated in a clinical example: patient, 19 years old, complaining of itchy, flaky rashes in the face and neck area, existing for 3 weeks. Based on the clinical picture, a diagnosis was made: atopic dermatitis of the face and neck. Given the multifaceted cause of the condition, namely the participation of both a pronounced immune response characteristic of AD, active colonization by Malassezia fungi, as well as open “gates” for secondary bacterial infection in the form of erosions, the prescription of a topical glucocorticosteroid was pathogenetically justified.
- 30 March 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 2,p. 42-48
Open AccessRecognizing secondary infection in patients with atopic dermatitis: Head & neck atopic dermatitis
Atopic dermatitis is a hereditary chronic skin disease characterized by severe itching, recurrent course and association with other diseases of atopic nature, as well as numerous complications, which include the addition of a secondary infection. Head and neck atopic dermatitis (HNAD) is a special phenotype of atopic dermatitis that occurs in adolescents and adults. A characteristic feature of HNAD is the lesion of skin areas rich in sebaceous glands (face, neck, upper third of the chest and back), which is associated with the active participation of Malassezia fungi in the pathogenesis of the dermatosis. The multifactorial pathogenesis of HNAD, often persistent course, the impossibility of complete elimination of the provoking factor, as well as the addition of a secondary bacterial infection against the background of itching, necessitate a comprehensive approach to the treatment of this condition and the use of combination drugs containing a glucocorticosteroid, an antimycotic and an antibiotic to relieve exacerbations. The article examines the etiology, mechanisms of development of HNAD, clinical features, as well as modern methods of therapy, the practical application of which is demonstrated in a clinical example: patient, 19 years old, complaining of itchy, flaky rashes in the face and neck area, existing for 3 weeks. Based on the clinical picture, a diagnosis was made: atopic dermatitis of the face and neck. Given the multifaceted cause of the condition, namely the participation of both a pronounced immune response characteristic of AD, active colonization by Malassezia fungi, as well as open “gates” for secondary bacterial infection in the form of erosions, the prescription of a topical glucocorticosteroid was pathogenetically justified.
- Open Access
- 25 February 2025
- Published by Paediatrician Publishers LLC in Current Pediatrics
- Vol. 24 (1) , 19-25
Long QT Syndrome Course Associated with New Coronavirus Infection. Clinical Case
Background. Long QT syndrome is hereditary disease, cardiac canalopathy variant, characterized by syncope and high risk of sudden cardiac death due to occurrence of polymorphic ventricular tachycardia (VT), torsade de pointes, and ventricular fibrillation. Acute respiratory viral infection may aggravate clinical course of primary electrical heart diseases. Clinical case description. 14-year-old female patient was transferred to infectious diseases hospital from another hospital with positive PCR test on new coronavirus infection (COVID-19) after loss of consciousness in November 2021. Syncope was first noted at the age of 12, however then did not recur, and their examination and treatment were postponed due to the COVID-19 pandemic. Syncopal states continued during COVID-19. Cardiac examination was performed at infectious diseases hospital: recurrent VT, torsade de pointes, was diagnosed along with QT interval prolongation. The girl's condition has improved after the treatment and selection of antiarrhythmic therapy. 15 days later negative PCR test for SARS-CoV-2 was received, and the patient was transferred to specialized hospital, where the long QT syndrome was confirmed, and dual-chamber cardioverter defibrillator was installed. Conclusion. This clinical case demonstrates that ARVI can aggravate the course of existing primary arrhythmia and emphasizes the crucial role of timely diagnosis and integrated approach to the management of patients with genetically determined cardiac arrhythmias.
- 25 February 2025
- Published by Paediatrician Publishers LLC in Current Pediatrics
- Vol. 24 (1) , 19-25
Open AccessLong QT Syndrome Course Associated with New Coronavirus Infection. Clinical Case
Background. Long QT syndrome is hereditary disease, cardiac canalopathy variant, characterized by syncope and high risk of sudden cardiac death due to occurrence of polymorphic ventricular tachycardia (VT), torsade de pointes, and ventricular fibrillation. Acute respiratory viral infection may aggravate clinical course of primary electrical heart diseases. Clinical case description. 14-year-old female patient was transferred to infectious diseases hospital from another hospital with positive PCR test on new coronavirus infection (COVID-19) after loss of consciousness in November 2021. Syncope was first noted at the age of 12, however then did not recur, and their examination and treatment were postponed due to the COVID-19 pandemic. Syncopal states continued during COVID-19. Cardiac examination was performed at infectious diseases hospital: recurrent VT, torsade de pointes, was diagnosed along with QT interval prolongation. The girl's condition has improved after the treatment and selection of antiarrhythmic therapy. 15 days later negative PCR test for SARS-CoV-2 was received, and the patient was transferred to specialized hospital, where the long QT syndrome was confirmed, and dual-chamber cardioverter defibrillator was installed. Conclusion. This clinical case demonstrates that ARVI can aggravate the course of existing primary arrhythmia and emphasizes the crucial role of timely diagnosis and integrated approach to the management of patients with genetically determined cardiac arrhythmias.
- 16 June 2024
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 21 (2) , 321-332
Modern possibilities of allergy diagnostics in real clinical practice
More than 20% of people worldwide suffer from allergic diseases. The high prevalence and wide range of provocative factors, which are increasing daily, complicate the diagnostic search. On the one hand, this leads to inadequately extensive dietary and lifestyle restrictions that reduce the quality of life for patients; on the other hand, it results in the failure to identify life-threatening allergens. The discovery of immunoglobulin E over 60 years ago initiated the search for specific biomarkers to etermine the causes of allergic diseases. Traditional methods of allergen diagnostics have several limitations that hinder the search for potential allergic disease triggers. The article discusses modern laboratory approaches to multicomponent molecular allergen diagnostics, describes its differences from traditional diagnostic methods, and analyzes the advantages, prospects, limitations, and shortcomings of this method. It also presents a comparative characterization of the test systems available today. The article presents four clinical cases that demonstrate the capabilities of the multicomponent ALEX 2 test system in diagnostics, choice of therapy tactics, and in forming further personalized recommendations for patients suffering from various allergic diseases.
- 16 June 2024
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 21 (2) , 321-332
Modern possibilities of allergy diagnostics in real clinical practice
More than 20% of people worldwide suffer from allergic diseases. The high prevalence and wide range of provocative factors, which are increasing daily, complicate the diagnostic search. On the one hand, this leads to inadequately extensive dietary and lifestyle restrictions that reduce the quality of life for patients; on the other hand, it results in the failure to identify life-threatening allergens. The discovery of immunoglobulin E over 60 years ago initiated the search for specific biomarkers to etermine the causes of allergic diseases. Traditional methods of allergen diagnostics have several limitations that hinder the search for potential allergic disease triggers. The article discusses modern laboratory approaches to multicomponent molecular allergen diagnostics, describes its differences from traditional diagnostic methods, and analyzes the advantages, prospects, limitations, and shortcomings of this method. It also presents a comparative characterization of the test systems available today. The article presents four clinical cases that demonstrate the capabilities of the multicomponent ALEX 2 test system in diagnostics, choice of therapy tactics, and in forming further personalized recommendations for patients suffering from various allergic diseases.
- Open Access
- 10 August 2021
- Published by Paediatrician Publishers LLC in Current Pediatrics
- Vol. 20 (3) , 223-231
Formula Alternatives for Nutrition Therapy of Children with Cow’s Milk Protein Allergy
Well-recognized tactic for the management of formula-fed children with cow’s milk protein allergy (CMPA) is exclusion of whole cow milk protein and its replacement with extensively hydrolyzed or amino acid formula. One of the most topical issue is the choice of therapeutic formula for a child with CMPA. This article presents information about the clinical manifestations of CMPA and describes the principles of nutrition therapy. All the stages of preparation of adapted therapeutic formula are discussed in detail. It has been shown that the choice of therapeutic formula for a child with CMPA depends on the disease clinical manifestations, their severity, and the presence of comorbid conditions. Current requirements for extensively hydrolyzed formula are reduced to limitations in the size of peptides with immunoreactive properties and indicate the need for evidence of the clinical efficacy of such formula in double-blind placebo-controlled studies.
- 10 August 2021
- Published by Paediatrician Publishers LLC in Current Pediatrics
- Vol. 20 (3) , 223-231
Open AccessFormula Alternatives for Nutrition Therapy of Children with Cow’s Milk Protein Allergy
Well-recognized tactic for the management of formula-fed children with cow’s milk protein allergy (CMPA) is exclusion of whole cow milk protein and its replacement with extensively hydrolyzed or amino acid formula. One of the most topical issue is the choice of therapeutic formula for a child with CMPA. This article presents information about the clinical manifestations of CMPA and describes the principles of nutrition therapy. All the stages of preparation of adapted therapeutic formula are discussed in detail. It has been shown that the choice of therapeutic formula for a child with CMPA depends on the disease clinical manifestations, their severity, and the presence of comorbid conditions. Current requirements for extensively hydrolyzed formula are reduced to limitations in the size of peptides with immunoreactive properties and indicate the need for evidence of the clinical efficacy of such formula in double-blind placebo-controlled studies.
- Open Access
- 27 October 2019
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 18 (3) , 183-191-191
Asthma and obesity in children: what do we know?
The results of a large number of studies indicate the relationship of obesity and bronchial asthma in children. The review highlights the mechanisms of development of the so-called obese asthma: morphological changes in the respiratory tract, systemic inflammation, adipokine production, impaired glucose and insulin metabolism, genetic and epigenetic factors, changes in the microbiome of the respiratory tract and(or) intestines. The relationship of asthma and obesity can have both a genetic basis and can occur under the influence of a complex of pathogenic factors, and they can be especially important at the “early programming” stage. Obesity increases the risk of asthma development, and in patients with existing asthma due to a number of mechanisms it increases the severity or makes it difficult to achieve control of asthma. Studies showed that patients with obese asthma are distinguished by a more severe course of the disease, poor quality of life and a decreased response to therapy for asthma. Weight loss in children with asthma can lead to an improved well-being of patients, but data on the effectiveness of therapeutic interventions in these children is limited. Comorbidity of asthma and obesity is a complex multifactorial phenotype in children, which requires further study. Being overweight or obese needs to be taken into account as part of asthma treatment in this category of patients.
- 27 October 2019
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 18 (3) , 183-191-191
Open AccessAsthma and obesity in children: what do we know?
The results of a large number of studies indicate the relationship of obesity and bronchial asthma in children. The review highlights the mechanisms of development of the so-called obese asthma: morphological changes in the respiratory tract, systemic inflammation, adipokine production, impaired glucose and insulin metabolism, genetic and epigenetic factors, changes in the microbiome of the respiratory tract and(or) intestines. The relationship of asthma and obesity can have both a genetic basis and can occur under the influence of a complex of pathogenic factors, and they can be especially important at the “early programming” stage. Obesity increases the risk of asthma development, and in patients with existing asthma due to a number of mechanisms it increases the severity or makes it difficult to achieve control of asthma. Studies showed that patients with obese asthma are distinguished by a more severe course of the disease, poor quality of life and a decreased response to therapy for asthma. Weight loss in children with asthma can lead to an improved well-being of patients, but data on the effectiveness of therapeutic interventions in these children is limited. Comorbidity of asthma and obesity is a complex multifactorial phenotype in children, which requires further study. Being overweight or obese needs to be taken into account as part of asthma treatment in this category of patients.